SECURE-CODE-WARRIOR
2.6.2022 14:02:13 CEST | Business Wire | Press release
Secure Code Warrior , the global, developer-driven security leader, today announced an exciting addition to the Okta Integration Network. Okta , the leading independent provider of identity, and Secure Code Warrior collaborated to deliver a new solution - the Secure Code Warrior (SCW) Connector for Okta Workflows, which enables organizations and developers to write secure code from the start of the software development lifecycle (SDLC).
Applying a security-first mindset, organizations can design an identity workflow that protects builds from the beginning of the life cycle, giving organizations the flexibility to only provide GitHub repo access to security proficient developers. This helps organizations promote a security first culture while the SCW Learning Platform enables developers to meet these standards and requirements. Organizations have implemented this solution across their application, security and engineering teams to provide this additional layer of security.
Preventing insecure code and ensuring better access control during software development remains a significant need for industries across all verticals. Meanwhile, developers recognize the importance of delivering secure software applications but face competing priorities. According to SCW’s recently released “The State of Developer-Driven Security Survey, 2022” , 67% knowingly left vulnerabilities and exploits in their code, with a lack of time and a cohesive approach cited as the two main barriers to the adoption of secure coding practices.
“This new solution will help organizations reduce the risk of developers committing insecure code by ensuring that employees are up to date on the latest vulnerabilities and secure coding techniques. Through our work together with Okta on a security proficiency check, AppSec Managers can be confident that the team is committing secure code without moving developers out of their workflow. Now, leaders can focus on broad strategic efforts to improve the organization’s security posture without sacrificing quality or time.” said Pieter Danhieux, Co-founder and CEO, Secure Code Warrior.
“Okta Workflows provides a no-code, low-code approach to automating identity-centric processes at scale. As an early adopter of Workflows Connector Builder, we are excited to have the new Secure Code Warrior connector in the Okta Integration Network, which goes beyond SSO and provisioning to support advanced integration flows. Developers can be confident that their secure code knowledge is up to date and relevant to the code they are committing” said David Shackelford, Senior Director, Okta.
The Secure Code Warrior Connector for Okta Workflows utilizes key components of both companies’ technology platforms to benefit organizations and developers alike:
- Pre-configured actions enable developer teams to quickly build the desired workflows in a no-code/low code environment, without the hassle of getting into the complexities of API calls.
- Once the workflow is ready, it will run automatically and can be customized for frequency.
- Secure Code Warrior’s Learning Platform provides information on the developers’ assessment score and course completion status, giving teams the insights to determine their security skills when writing code.
- Organizations have the flexibility to only allow GitHub repo access to security proficient developers
Creating and automating secure developer workflows is now easier than ever thanks to this new industry solution from Secure Code Warrior and Okta. The Secure Code Warrior Connector for Okta Workflows is available at https://help.okta.com/wf/en-us/Content/Topics/Workflows/connector-reference/securecodewarrior/securecodewarrior.htm .
To learn more, visit www.securecodewarrior.com/blog/scw-connector-for-okta-workflows .
About Secure Code Warrior
Secure Code Warrior builds a culture of security-driven developers by giving them the skills to code securely. Our flagship Learning Platform delivers relevant skills-based pathways, hands-on missions, and contextual tools for developers to rapidly learn, build, and apply their skills to write secure code at speed. Established in 2015, Secure Code Warrior has become a critical component for over 450 enterprises including leading financial services, retail, and global technology companies across the world. Visit: www.securecodewarrior.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005007/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release
Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin
DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 11:21:00 CEST | Press release
Poster presented at ESMO Breast Cancer 2026: Exploring health policy and real-world treatment strategies for early-stage HER2-positive breast cancer across Europe. The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
